Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) represents the most important type of liver cancer, the 5-year survival rate for advanced HCC is 2%. The heterogeneity of HCC makes previous models fail to achieve satisfactory results. The role of Cholesterol-based metabolic reprogramming in cancer has attracted more...
Main Authors: | Linsong Tang, Rongli Wei, Ronggao Chen, Guanghan Fan, Junbin Zhou, Zhetuo Qi, Kai Wang, Qiang Wei, Xuyong Wei, Xiao Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Computational and Structural Biotechnology Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2001037022003105 |
Similar Items
-
Comprehensive analysis of metabolic pathway activity subtypes derived prognostic signature in hepatocellular carcinoma
by: Junyu Huo, et al.
Published: (2023-01-01) -
Genomic Instability of Mutation-Derived Gene Prognostic Signatures for Hepatocellular Carcinoma
by: Ze-Bing Song, et al.
Published: (2021-10-01) -
Development of a prognostic gene signature for hepatocellular carcinoma
by: Cuiyun Wu, et al.
Published: (2022-01-01) -
Five-CpG-based prognostic signature for predicting survival in hepatocellular carcinoma patients
by: Feng Fang, et al.
Published: (2018-12-01) -
A Novel Prognostic Signature Associated with Immunotherapeutic Response for Hepatocellular Carcinoma
by: Xinmin Jin, et al.
Published: (2022-07-01)